Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
Mark Crowther shared a noteworthy post honoring Dr. Davide Matino, faculty member of McMaster University Department of Medicine, on LinkedIn:
“Incredible breakthroughs are happening right here in Hamilton – and McMaster University is at the heart of it.
A promising new hemophilia treatment – described as “life-transforming”- is being tested on local patients, bringing hope to thousands across Canada.
Leading this cutting-edge clinical trial is Dr. Davide Matino, a faculty member in McMaster University Department of Medicine, which boasts decades of global research excellence in hemostasis and thrombosis.
This isn’t just a milestone in medicine-it’s a powerful reminder of the impact academic research can have when paired with compassion and collaboration.
McMaster’s Faculty of Health Sciences continues to lead the way in advancing care and improving lives, both locally and globally.”
Read more about this exciting development here.
Stay uptaded on hematology world news with Hemostasis Today:
-
Oct 7, 2025, 08:27John Chuback - Blood Clots: The Silent Killer
-
Oct 7, 2025, 04:20Nita Radhakrishnan to Present The First Indian Collaborative Data on Hemophilia from the WBDR Registry
-
Oct 6, 2025, 17:51Klaus Mönkemüller Just Released "The EndoCollab Guide for GI Bleeding" For Endoscopists
-
Oct 6, 2025, 08:10Haemophilia Foundation Australia: Animals Can Have Bleeding Disorders Too!
-
Oct 6, 2025, 08:03Peter Libby: Exploring Inflammation in Atherosclerosis: Lessons and Therapeutic Implications
-
Oct 7, 2025, 08:31Brooke Wolford Leads Groundbreaking GWAS Study Identifying Novel Genetic Loci for Venous Thromboembolism
-
Oct 7, 2025, 08:25ImmuneLink LLC Research: Role of Interferon-Gamma (IFN-γ) in Pathophysiology and Management of Deep Vein Thrombosis
-
Oct 7, 2025, 03:56Nathan Connell: Interesting Data in The Management of HAC Has Been Published in Blood from Benoit Guillet and Colleagues
-
Oct 7, 2025, 03:40Nature Communications Study by Amelia Haj and Colleagues Identifies Factor XII as a Safer Target for Anticoagulation
-
Oct 7, 2025, 03:36Lisiena Hysenaj: Excited to Announce the Jeroen Roose Lab’s Latest Publication from Laila Karra Khalil
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 2, 2025, 04:572025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
-
Oct 7, 2025, 08:29“48 Poems on 48 Blood Group Systems” - Dr Bhavyaa Beriwal Blends Science and Poetry in Her New Transfusion Medicine Book
-
Oct 7, 2025, 04:35Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors
-
Oct 7, 2025, 04:09Svenja Tatjana Barckhausen: Reducing Reliance on U.S. Plasma – Not Just for Europe, But for The World!
-
Oct 7, 2025, 03:58Louise Bannon: Don’t Wait Until You’re Diagnosed to Learn About Blood Clots
-
Oct 6, 2025, 07:40Erin VanDyke: World Thrombosis Day Falls Right At The End Of PA Week, And It’s A Powerful Reminder Of Why I Do What I Do